跳至主要内容
临床试验/EUCTR2013-003842-18-NL
EUCTR2013-003842-18-NL进行中(未招募)1 期

Prevention of renal and bladder damage in children with spina bifida by means of early injections with Botulinum-Toxin-A (Botox): a pilot study. - Early Botox in SB patients.

Erasmus MC0 个研究点开始时间: 2014年1月6日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
Erasmus MC

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • The study group exists of newborns with MMC who are treated with the standard treatment (CIC and anticholinergics). The minimal age at inclusion is 3 months. This is because of the minimal diameter of the urethra which is necessary for cystoscopy.
  • The historical control group exists of MMC patients who have not been treated with Botox and who were born between 1998 and 2008.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 10
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • The exclusion criteria for the study group are:
  • - Patients with swallowing or breathing problems for which medical treatment is or was necessary.
  • - Muscle diseases such as myasthenia gravis, amyotrophic lateral sclerosis or the Syndrome of Eaton-Lambert.
  • For the historical group the database of (parents of) patients who object against the use of their medical records for research purposes.

研究者

发起方
Erasmus MC

相似试验